Genetic variants of reduced clopidogrel absorption and platelet reactivity after standard clopidogrel therapy and serial dose tailoring in the NCT02096419 trial: a pharmacogenetic substudy (CROSBI ID 685977)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Samardžić, Jure ; Božina, Nada ; Skorić, Boško ; Ganoci, Lana ; Krpan, Miroslav ; Petričević, Mate ; Miličić, Davor
engleski
Genetic variants of reduced clopidogrel absorption and platelet reactivity after standard clopidogrel therapy and serial dose tailoring in the NCT02096419 trial: a pharmacogenetic substudy
Genetic variants of reduced clopidogrel absorption and platelet reactivity after standard clopidogrel therapy and serial dose tailoring in the NCT02096419 trial: a pharmacogenetic substudy
clopidogrel ; acute coronary syndrome
Genetic variants of reduced clopidogrel absorption and platelet reactivity after standard clopidogrel therapy and serial dose. tailoring in the NCT02096419 trial: a pharmacogenetic substudy
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
205-205.
2015.
nije evidentirano
objavljeno
10.15836/ccar.2015.205
Podaci o matičnoj publikaciji
Cardiologia Croatica
Miličić, Davor
Zagreb: Hrvatsko kardiološko društvo
1848-543X
1848-5448
Podaci o skupu
4th Dubrovnik Cardiology Highlights an ESC Update Programme in Cardiology
poster
10.10.2015-13.10.2015
Dubrovnik, Hrvatska
